Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-19-003848)

Filing Details

Accession Number:: 0001179110-19-003848
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-03-14 16:16:37
Reporting Period:: 2019-03-14

Accepted Time:: 2019-03-14 16:16:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
720154	Bioanalytical Systems Inc	BASI	Services-Commercial Physical & Biological Research (8731)	351345024

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1746201	E John Sagartz	C/O Bioanalytical Systems, Inc. 2701 Kent Avenue West Lafayette IN 47906-1382		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2019-03-14	1,400	$1.94	3,900	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	617,625	Indirect	See Footnote

Footnotes

The Reporting Person owns 41.175% of the outstanding equity interests of SW Chrysalis, LLC, a Delaware limited liability company, which owns 1,500,000 common shares of the Issuer. The Reporting Person is Co-President and Chief Strategy Officer of SW Chrysalis, LLC.